Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Astrana Health Inc
ASTH
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$38.01
0.66
1.77%
Dern. MÀJ: Oct 22, 4:00 PM
$38.01
0.66
1.77%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Résultats:
Résultats Q3 2026 dans dans 14 jours à partir de maintenant le jeu. nov. 5th, après la fermeture du marché
Astrana Health Financials
Astrana Health (ASTH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est
Astrana Health (NASDAQ:ASTH) sees Q3 sales of $1.000 billion-$1.030 billion vs $1.021 billion analyst estimate.
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.34 by 17.65 percent. This is a 110.53 percent increase over earnings of $0.19 per share from
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $3.984B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $3.984 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Sees Q2 Sales $965.000M-$1.000B vs $973.326M Est
Astrana Health (NASDAQ:ASTH) sees Q2 sales of $965.000 million-$1.000 billion vs $973.326 million analyst estimate.
Benzinga Newsdesk
